# Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

> **NCT06821399** · — · RECRUITING · sponsor: **Yufan Wang** · enrollment: 2920 (estimated)

## Conditions studied

- Diabetes
- Diabetic Retinopathy
- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DIAGNOSTIC_TEST:** Fundus Examination
- **DIAGNOSTIC_TEST:** Metabolomics analysis

## Key facts

- **NCT ID:** NCT06821399
- **Lead sponsor:** Yufan Wang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 2920 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06821399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06821399, "Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06821399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*